Protara Therapeutics, Inc. (TARA)
3.965
+0.02
(+0.63%)
USD |
NASDAQ |
Sep 03, 16:00
3.965
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Net Income (Annual) : -57.44M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -57.44M |
| December 31, 2024 | -44.60M |
| December 31, 2023 | -40.42M |
| December 31, 2022 | -65.95M |
| December 31, 2021 | -47.25M |
| December 31, 2020 | -33.98M |
| December 31, 2019 | -7.83M |
| Date | Value |
|---|---|
| December 31, 2018 | -20.73M |
| December 31, 2017 | -29.96M |
| December 31, 2016 | -28.53M |
| December 31, 2015 | -21.38M |
| December 31, 2014 | -3.342M |
| December 31, 2013 | -7.912M |
| December 31, 2012 | -7.97M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| NovelStem International Corp. | 2.380M |
| Brainstorm Cell Therapeutics, Inc. | -10.31M |
| Summit Therapeutics, Inc. | -1.080B |
| Kezar Life Sciences, Inc. | -56.03M |
| Clene, Inc. | -26.17M |